Gufic Biosciences Limited ("the Company") announces to launch Botulinum Neurotoxin in India in collaboration with USA based Company Prime Bio, Inc., led by Dr. Bal Ram Singh.
The Company has received regulatory approval to manufacture and market Botulinum Neurotoxin.
The Company is an indigenous manufacturing company to launch such project in India with a robust and inherent world class infrastructure which will help the Company to bring the cost effective option of this toxin to India and also expand them to middle east, East and Southeast Asia.
- Botulinum Neurotoxin is provided by a kind of bacteria called as clostridium botulinum. Botulinum Neurotoxin is used in therapeutic and aesthetic procedures.
- Some of the Clinical Uses are mentioned below:
- Movement Disorders
- Pain Syndromes
There are total 137 disorders for which clinical data is available.
Shares of GUFIC BIOSCIENCES LTD. was last trading in BSE at Rs.69.45 as compared to the previous close of Rs. 70.5. The total number of shares traded during the day was 8433 in over 165 trades.
The stock hit an intraday high of Rs. 70.05 and intraday low of 68.45. The net turnover during the day was Rs. 584264.